Moderna shares rise on quarterly revenue beat despite wider-than-expected lossProactive Investors • 02/14/25
Will Moderna's Retained 2025 Outlook Bolster Its Depressed Shares?Investors Business Daily • 02/14/25
Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business UpdatesAccesswire • 02/14/25
Moderna Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate AnalystsBenzinga • 02/14/25
Insights Into Moderna (MRNA) Q4: Wall Street Projections for Key MetricsZacks Investment Research • 02/11/25
20 stocks leading the stock-market plunge on Monday as Trump brings down the tariff hammerMarket Watch • 02/03/25
Ethris Presents Positive Topline Phase 1 Data with mRNA Lead Candidate ETH47 for Uncontrolled AsthmaBusiness Wire • 01/30/25